TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $597,096 | -81.6% | 71,423 | -45.4% | 0.01% | -83.1% |
| Q2 2023 | $3,246,439 | +78.6% | 130,694 | +8.1% | 0.07% | +61.4% |
| Q1 2023 | $1,818,140 | +21.5% | 120,887 | -4.4% | 0.04% | +4.8% |
| Q4 2022 | $1,495,809 | +188.8% | 126,442 | +1075.5% | 0.04% | +82.6% |
| Q1 2021 | $518,000 | -70.5% | 10,756 | -68.1% | 0.02% | -60.3% |
| Q4 2020 | $1,754,000 | +94.5% | 33,716 | +0.0% | 0.06% | +100.0% |
| Q3 2020 | $902,000 | +3.4% | 33,700 | -24.8% | 0.03% | +11.5% |
| Q2 2020 | $872,000 | +1306.5% | 44,788 | +303.3% | 0.03% | +2500.0% |
| Q3 2019 | $62,000 | – | 11,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 1,647,000 | $6,423,000 | 0.45% |
| DAFNA Capital Management LLC | 75,000 | $293,000 | 0.30% |
| Baker Brothers Advisors | 2,199,656 | $8,579,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 71,105 | $277,000 | 0.05% |
| SMITH ASSET MANAGEMENT GROUP LP | 196,684 | $767,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 66,000 | $257,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,000 | $4,000 | 0.01% |
| COLUMBUS CIRCLE INVESTORS | 161,919 | $631,000 | 0.00% |
| JENNISON ASSOCIATES LLC | 455,271 | $1,776,000 | 0.00% |
| BlackRock Fund Advisors | 448,445 | $1,749,000 | 0.00% |